Takeda Brazil sells Multilab
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Takeda Pharmaceutical is set to offload its Multilab Brazilian OTC and generics operation to Grupo NC – the parent group of pharmaceuticals firm EMS – for an undisclosed sum.